Result of AGM

RNS Number : 2977S
Assura PLC
07 July 2020
 

7 July 2020

Assura plc ("Company")

Result of AGM

 

Assura plc announces that at its Annual General Meeting held earlier today at the private residence of the Chairman, each of the resolutions submitted to the meeting (as set out in the Notice of the Meeting dated 5 June 2020) were passed by the requisite majorities on a poll.

Resolution

For

%

For

Against

% Against

Total Votes Cast (% of issued share capital)

Votes Withheld

1. To receive the Company's report and accounts 

2,046,450,959

99.79

4,313,123

0.21

2,050,764,082 (77.10)

18,486,196

2. To approve the rules of the Share Incentive Plan

2,049,923,435

99.07

19,260,961

0.93

2,069,184,396 (77.79)

65,882

3. To approve the Directors' Remuneration Report 

1,732,647,243

83.74

336,543,380

16.26

2,069,190,623 (77.79)

59,655

4. To re-appoint Deloitte LLP as auditor of the Company 

2,052,248,343

99.99

108,380

0.01

2,052,356,723 (77.16)

16,893,555

5. To authorise the Audit Committee to determine the auditor's remuneration 

2,069,198,449

99.99

42,898

0.01

2,069,241,347 (77.79)

8,931

6. To re-elect Ed Smith as a Director of the Company

2,055,912,319

99.36

13,320,795

0.64

2,069,233,114 (77.79)

17,164

7. To re-elect Louise Fowler as a Director of the Company

2,066,682,906

99.88

2,550,208

0.12

2,069,233,114 (77.79)

17,164

8. To re-elect Jonathan Murphy as a Director of the Company

2,061,677,628

99.63

7,555,486

0.37

2,069,233,114 (77.79)

17,164

9. To re-elect

Jenefer Greenwood as a Director of the Company

1,988,885,113

96.12

80,348,001

3.88

2,069,233,114 (77.79)

17,164

10. To re-elect Jayne Cottam as a Director of the Company

2,053,645,096

99.25

15,588,018

0.75

2,069,233,114 (77.79)

17,164

11. To re-elect Jonathan Davies as a Director of the Company

2,066,395,556

99.86

2,837,558

0.14

2,069,233,114 (77.79)

17,164

12. To authorise the Directors to allot shares

1,977,103,760

95.59

91,174,425

4.41

2,068,278,185 (77.76)

972,093

13. To empower the Directors to disapply pre-emption rights

2,068,990,973

99.99

251,069

0.01

2,069,242,042 (77.79)

8,236

14. To empower the Directors to disapply pre-emption rights in connection with an acquisition or specified capital investment

2,043,292,892

98.79

24,977,293

1.21

2,068,270,185 (77.75)

980,093

15. To authorise the market purchase of the Company's own shares

2,032,042,863

98.33

34,551,627

1.67

2,066,594,490(77.69)

2,655,788

16. To authorise the Company to call any general meeting, other than the Annual General Meeting, by not less than 14 clear days' notice

1,924,533,046

93.01

144,715,232

6.99

2,069,248,278 (77.79)

2,000

Resolutions 1-12 were passed as ordinary resolutions. Resolutions 13-16 were passed as special resolutions. Votes 'For' include votes at the discretion of the Chairman. 

Notes:

1. The percentages above are rounded to two decimal places.

2. A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "for" and "against" a resolution.

3. The number of ordinary shares in issue on the share register at 6.00pm on 6 July 2020 was 2,659,993,187 of which the Total Voting Rights figure was 2,659,993,187.

Copies of resolutions 13-16, being resolutions other than resolutions concerning ordinary business passed by the Company at the above AGM, have been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

- Ends -

For more information, please contact:

 

Assura plc

 

Tel: 01925 420680

Orla Ball, Company Secretary

David Purcell, Head of Financial Reporting

Email: Investor@assura.co.uk

 

Finsbury
Gordon Simpson

 

Tel: 0207 251 3801
Email: Assura@finsbury.com

James Thompson

 


 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2020, Assura's property portfolio was valued at £2,139 million.

Further information is available at www.assuraplc.com  

*EPRA is a registered trademark of the European Public Real Estate Association.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGSSFFLWESSEFW

Companies

Assura (AGR)
UK 100